AEM vs AVD

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

American Vanguard Corporation (AVD) exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9—indicating extreme weakness in operational and financial health. The company reports negative profitability across key metrics, including a -21.15% profit margin and -40.84% ROE, with no sign of sustainable earnings. Despite a low Price/Book of 0.46 and a 52-week low of $3.28, the stock remains deeply undervalued on a fundamental basis, but this is likely due to persistent losses and high risk. The absence of an Altman Z-Score and the company's negative earnings trajectory suggest significant distress risk. The recent earnings surprises are overwhelmingly negative, with a -231.11% average surprise over the last four quarters, reinforcing the bearish outlook.